| scholarly article | Q13442814 |
| P50 | author | Gordon B. Mills | Q28086262 |
| Robert C. Bast | Q37841724 | ||
| Zahid H Siddik | Q95937674 | ||
| P2093 | author name string | Khokhar AR | |
| Hagopian GS | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | platinum | Q880 |
| ovarian cancer | Q172341 | ||
| P304 | page(s) | 655-663 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV) | |
| P478 | volume | 5 |
| Q54859210 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation. |
| Q42544263 | A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells. |
| Q37194722 | An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells |
| Q49256920 | Antihepatocellular Carcinoma Potential of Tetramethylpyrazine Induces Cell Cycle Modulation and Mitochondrial-Dependent Apoptosis: Regulation of p53 Signaling Pathway in HepG2 Cells In Vitro |
| Q34397197 | Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer |
| Q37706855 | Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells |
| Q33218808 | Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. |
| Q37379821 | Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells |
| Q29248201 | Functional activation of mutant p53V172F by platinum analogs in cisplatin-resistant human tumor cells is dependent on serine-20 phosphorylation |
| Q35281886 | Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth |
| Q34335251 | Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells |
| Q35738714 | Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation |
| Q36318784 | MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog |
| Q90371047 | Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents |
| Q37659410 | Recent developments in texaphyrin chemistry and drug discovery |
| Q27006998 | Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53 |
| Q36920272 | Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin. |
| Q35892810 | Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses |
| Q40630934 | Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents. |
| Q36930841 | Synergy between PPARgamma ligands and platinum-based drugs in cancer |
| Q36697283 | The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog |
| Q87851103 | The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: Effects in human colorectal HCT116 TP53(+/+), TP53(+/-) and TP53(-/-) cells |
| Q40089378 | Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription. |
| Q36612511 | Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21 |
Search more.